Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
415.00
+35.00 (9.21%)
Last updated: Mar 10, 2026, 3:32 PM HKT

HKG:6990 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
88,61137,11322,555--
Market Cap Growth
113.64%64.54%---
Enterprise Value
83,80834,05420,931--
Last Close Price
380.00163.30102.90--
PS Ratio
53.8918.0413.29--
PB Ratio
16.1310.548.79--
P/TBV Ratio
16.1310.558.79--
P/OCF Ratio
--343.75--
EV/Sales Ratio
50.9616.5512.33--
Debt / Equity Ratio
0.030.040.03-0.93-0.90
Net Debt / Equity Ratio
-0.87-0.89-1.04-0.91-0.87
Net Debt / EBITDA Ratio
6.0517.965.79-7.94-2.98
Net Debt / FCF Ratio
5.365.80113.36-9.59-3.98
Asset Turnover
0.310.500.680.89-
Inventory Turnover
4.937.6013.515.36-
Quick Ratio
6.234.092.350.050.04
Current Ratio
6.574.312.530.080.09
Return on Equity (ROE)
-17.56%-9.46%---
Return on Assets (ROA)
-9.92%-3.41%-12.60%-27.27%-
Return on Capital Employed (ROCE)
-15.00%-6.10%-18.90%12.40%30.20%
Earnings Yield
-0.89%-0.77%-2.80%--
FCF Yield
-1.01%-1.45%-0.10%--
Buyback Yield / Dilution
-3.66%-20.70%-92.24%-3.31%-
Source: S&P Capital IQ. Standard template. Financial Sources.